Literature DB >> 30295095

Pathogenesis of adult onset still's disease: current understanding and new insights.

Piero Ruscitti1, Roberto Giacomelli1.   

Abstract

INTRODUCTION: Adult-onset Still's disease (AOSD) is a rare inflammatory disorder typically characterized by fever, arthritis, and hyperferritinemia. Concerning AOSD pathogenesis, it is categorized as a multigenic autoinflammatory disease, at the 'crossroads' of autoinflammatory and autoimmune diseases, because of the involvement of both arms of immune system. Areas covered: This work is conceived as narrative overview assessing the pathogenesis of AOSD. We performed a narrative synthesis of published information, summarizing the contents of previous studies and providing a possible rationale for future researches. MedLine database was searched for identification of suitable studies. In reporting the available evidence, we described the results according to distinct pathogenic steps associated with different clinical features of the disease. Expert commentary: AOSD is a systemic severe inflammatory disorder of unknown etiology affecting young adults. Although pathogenesis of the disease is not fully clarified, the role of the pro-inflammatory cytokines is well-recognized and biologic drugs, blocking these molecules, are routinely used in clinical practice. Finally, given that multiple recent lines of evidence have suggested new insights in AOSD pathogenesis, new therapeutic targets have been highlighted and the results of studies with new drugs could further improve the management of these patients.

Entities:  

Keywords:  Adult onset still’s disease; ferritin; inflammation; macrophage activation syndrome; pathogenesis; therapy

Mesh:

Substances:

Year:  2018        PMID: 30295095     DOI: 10.1080/1744666X.2018.1533403

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  15 in total

1.  Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.

Authors:  Piero Ruscitti; Paola Cipriani; Vasiliki Liakouli; Daniela Iacono; Ilenia Pantano; Francesco Caso; Federico Perosa; Fabiola Atzeni; Francesco Paolo Cantatore; Raffaele Scarpa; Francesco Ciccia; Roberto Giacomelli
Journal:  Rheumatol Int       Date:  2019-07-01       Impact factor: 2.631

2.  The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.

Authors:  Piero Ruscitti; Onorina Berardicurti; Ilenia Di Cola; Claudia Di Muzio; Elena Di Nino; Roberto Giacomelli; Paola Cipriani
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

3.  Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.

Authors:  Piero Ruscitti; Ilenia Di Cola; Onorina Berardicurti; Alessandro Conforti; Daniela Iacono; Ilenia Pantano; Gelsomina Rozza; Silvia Rossi; Ludovico De Stefano; Silvia Balduzzi; Antonio Vitale; Francesco Caso; Luisa Costa; Marcella Prete; Luca Navarini; Fabiola Atzeni; Giuliana Guggino; Federico Perosa; Luca Cantarini; Bruno Frediani; Carlomaurizio Montecucco; Francesco Ciccia; Roberto Giacomelli; Paola Cipriani
Journal:  Clin Rheumatol       Date:  2021-10-11       Impact factor: 3.650

4.  The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.

Authors:  Piero Ruscitti; Onorina Berardicurti; Ilenia Di Cola; Claudia Di Muzio; Elena Di Nino; Roberto Giacomelli; Paola Cipriani
Journal:  Clin Exp Immunol       Date:  2022-02-02       Impact factor: 5.732

5.  Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India.

Authors:  S Chandrashekara; Vineeta Shobha; Vijay Rao; Anu Desai; Ramesh Jois; B G Dharmanand; Sharath Kumar; Pradeep Kumar; Chethana Dharmapalaiah; Kurugodu Mathada Mahendranath; Shiva Prasad; Manisha Ashwin Daware; Yogesh Singh; Uma Karjigi; S Nagaraj; K R Anupama
Journal:  Rheumatol Int       Date:  2019-01-25       Impact factor: 2.631

6.  The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still's disease. A systematic review and meta-analysis of observational studies.

Authors:  Piero Ruscitti; Francesco Ursini; Jurgen Sota; Roberto De Giorgio; Luca Cantarini; Roberto Giacomelli
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-06-17       Impact factor: 5.346

7.  Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients.

Authors:  Piero Ruscitti; Onorina Berardicurti; Daniela Iacono; Ilenia Pantano; Vasiliki Liakouli; Francesco Caso; Giacomo Emmi; Rosa Daniela Grembiale; Francesco Paolo Cantatore; Fabiola Atzeni; Federico Perosa; Raffaele Scarpa; Giuliana Guggino; Francesco Ciccia; Antonio Barile; Paola Cipriani; Roberto Giacomelli
Journal:  Arthritis Res Ther       Date:  2020-06-22       Impact factor: 5.156

8.  The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile.

Authors:  Piero Ruscitti; Antonio Barile; Onorina Berardicurti; Roberto Giacomelli; Paola Cipriani; Sonia Iafrate; Paola Di Benedetto; Antonio Vitale; Francesco Caso; Luisa Costa; Federico Bruno; Francesco Ursini; Luca Navarini; Federica Sensini; Raffaele Scarpa; Bruno Frediani; Luca Cantarini; Carlo Masciocchi
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

9.  Elevated serum levels of checkpoint molecules in patients with adult Still's disease.

Authors:  Yuya Fujita; Tomoyuki Asano; Haruki Matsumoto; Naoki Matsuoka; Jumpei Temmoku; Shuzo Sato; Makiko Yashiro Furuya; Eiji Suzuki; Hiroshi Watanabe; Tomohiro Koga; Atsushi Kawakami; Kiyoshi Migita
Journal:  Arthritis Res Ther       Date:  2020-07-22       Impact factor: 5.156

10.  Genetic Association and Expression Correlation between Colony-Stimulating Factor 1 Gene Encoding M-CSF and Adult-Onset Still's Disease.

Authors:  Yi-Ming Chen; Wei-Ting Hung; Wan-Chun Chang; Chia-Wei Hsieh; Wen-Hung Chung; Joung-Liang Lan; Ning-Rong Gung; Yun-Shien Lee; Der-Yuan Chen; Shuen-Iu Hung
Journal:  J Immunol Res       Date:  2020-02-14       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.